Neurocrine Makes Huge M&A Deal With Nearly $3B Soleno Buyout

April 7, 2026

BioAgilytix snaps MicroConstants to further build contract research services

September 7, 2021

Lilly Acquires Orna to Enter In Vivo CAR-T Development for Autoimmune Diseases

February 12, 2026

Must Read

Top 10 Emerging Trends in Life Sciences for 2026

April 28, 2026

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

April 28, 2026

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

April 28, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Oruka Therapeutics Reports Phase 2a Psoriasis Data Showing 63.5% Skin Clearance with ORKA-001

TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus

Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial

Actuate Therapeutics medication increases survival chances in pancreatic cancer trial

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

Tag: Lilly

Lilly Licenses CSL’s Phase 3 IL-6 Antibody Clazakizumab in $100 Million Upfront Deal

Editor Picks

Neurocrine Makes Huge M&A Deal With Nearly $3B Soleno Buyout

BioAgilytix snaps MicroConstants to further build contract research services

Lilly Acquires Orna to Enter In Vivo CAR-T Development for Autoimmune Diseases

Must Read

Top 10 Emerging Trends in Life Sciences for 2026

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Hot Topics

About Us

Follow Us